# Brookdale Senior Living Inc.: financial statements, quarterly

BKD · NYSE · CIK 1332349 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkd.md) · [Financials](/companies/bkd/financials.md) · [Filings](/companies/bkd/filings.md) · [Insiders](/companies/bkd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [757](/filings/0001332349-24-000129.md) | [754 d](/filings/0001332349-26-000032.md) | [783](/filings/0001332349-25-000100.md) | [778](/filings/0001332349-25-000129.md) | [784](/filings/0001332349-25-000143.md) | [781 d](/filings/0001332349-26-000032.md) | [814](/filings/0001332349-26-000048.md) | [813](/filings/0001332349-26-000064.md) | [813](/filings/0001332349-25-000143.md) | [754 d](/filings/0001332349-26-000032.md) | [765](/filings/0001332349-26-000048.md) | [719](/filings/0001332349-26-000064.md) |
| Gross profit | $m | [185](/filings/0001332349-24-000129.md) | [189 d](/filings/0001332349-26-000032.md) | [204](/filings/0001332349-25-000100.md) | [205](/filings/0001332349-25-000129.md) | [198](/filings/0001332349-25-000143.md) | [192 d](/filings/0001332349-26-000032.md) | [223](/filings/0001332349-26-000048.md) | [216](/filings/0001332349-26-000064.md) | [211](/filings/0001332349-25-000143.md) | [188 d](/filings/0001332349-26-000032.md) | [216](/filings/0001332349-26-000048.md) | [206](/filings/0001332349-26-000064.md) |
| Operating income | $m | [(6.3)](/filings/0001332349-24-000129.md) | [(24.2) d](/filings/0001332349-26-000032.md) | [19.2](/filings/0001332349-25-000100.md) | [19.2](/filings/0001332349-25-000129.md) | [10.3](/filings/0001332349-25-000143.md) | [(2.1) d](/filings/0001332349-26-000032.md) | [29.6](/filings/0001332349-26-000048.md) | [14.9](/filings/0001332349-26-000064.md) | [(53.8)](/filings/0001332349-25-000143.md) | [22.9 d](/filings/0001332349-26-000032.md) | [51.8](/filings/0001332349-26-000048.md) | [85.2](/filings/0001332349-26-000064.md) |
| Interest expense | $m | not reported | not reported | [57.7](/filings/0001332349-25-000100.md) | [61.6](/filings/0001332349-25-000129.md) | [66.3](/filings/0001332349-25-000143.md) | [67.0 d](/filings/0001332349-25-000037.md) | [65.0](/filings/0001332349-25-000100.md) | [63.1](/filings/0001332349-25-000129.md) | [63.6](/filings/0001332349-25-000143.md) | not reported | not reported | not reported |
| Income tax | $m | [(1.9)](/filings/0001332349-24-000129.md) | [9.8 d](/filings/0001332349-26-000032.md) | [(0.0)](/filings/0001332349-25-000100.md) | [0.4](/filings/0001332349-25-000129.md) | [0.7](/filings/0001332349-25-000143.md) | [3.6 d](/filings/0001332349-26-000032.md) | [(0.7)](/filings/0001332349-26-000048.md) | [(0.3)](/filings/0001332349-26-000064.md) | [0.2](/filings/0001332349-25-000143.md) | [(1.2) d](/filings/0001332349-26-000032.md) | [(0.4)](/filings/0001332349-26-000048.md) | [5.5](/filings/0001332349-26-000064.md) |
| Net income | $m | [(48.8)](/filings/0001332349-24-000129.md) | [(91.2) d](/filings/0001332349-26-000032.md) | [(29.6)](/filings/0001332349-25-000100.md) | [(37.7)](/filings/0001332349-25-000129.md) | [(50.7)](/filings/0001332349-25-000143.md) | [(83.9) d](/filings/0001332349-26-000032.md) | [(65.0)](/filings/0001332349-26-000048.md) | [(43.0)](/filings/0001332349-26-000064.md) | [(115)](/filings/0001332349-25-000143.md) | [(40.0) d](/filings/0001332349-26-000032.md) | [(6.9)](/filings/0001332349-26-000048.md) | [23.3](/filings/0001332349-26-000064.md) |
| Diluted EPS | $ per share | [(0.22)](/filings/0001332349-24-000129.md) | not reported | [(0.13)](/filings/0001332349-25-000100.md) | [(0.17)](/filings/0001332349-25-000129.md) | [(0.22)](/filings/0001332349-25-000143.md) | not reported | [(0.28)](/filings/0001332349-26-000048.md) | [(0.18)](/filings/0001332349-26-000064.md) | [(0.48)](/filings/0001332349-25-000143.md) | not reported | [(0.03)](/filings/0001332349-26-000048.md) | [0.10](/filings/0001332349-26-000064.md) |
| Basic EPS | $ per share | [(0.22)](/filings/0001332349-24-000129.md) | not reported | [(0.13)](/filings/0001332349-25-000100.md) | [(0.17)](/filings/0001332349-25-000129.md) | [(0.22)](/filings/0001332349-25-000143.md) | not reported | [(0.28)](/filings/0001332349-26-000048.md) | [(0.18)](/filings/0001332349-26-000064.md) | [(0.48)](/filings/0001332349-25-000143.md) | not reported | [(0.03)](/filings/0001332349-26-000048.md) | [0.10](/filings/0001332349-26-000064.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [332](/filings/0001332349-23-000104.md) | [278](/filings/0001332349-25-000037.md) | [319](/filings/0001332349-24-000078.md) | [290](/filings/0001332349-24-000102.md) | [255](/filings/0001332349-24-000129.md) | [309](/filings/0001332349-26-000032.md) | [240](/filings/0001332349-25-000100.md) | [252](/filings/0001332349-25-000129.md) | [253](/filings/0001332349-25-000143.md) | [279](/filings/0001332349-26-000064.md) | [265](/filings/0001332349-26-000048.md) | [370](/filings/0001332349-26-000064.md) |
| Current assets | $m | [594](/filings/0001332349-23-000104.md) | [478](/filings/0001332349-25-000037.md) | [516](/filings/0001332349-24-000078.md) | [493](/filings/0001332349-24-000102.md) | [474](/filings/0001332349-24-000129.md) | [513](/filings/0001332349-26-000032.md) | [454](/filings/0001332349-25-000100.md) | [467](/filings/0001332349-25-000129.md) | [537](/filings/0001332349-25-000143.md) | [554](/filings/0001332349-26-000064.md) | [553](/filings/0001332349-26-000048.md) | [597](/filings/0001332349-26-000064.md) |
| Total assets | $m | [5,829](/filings/0001332349-23-000104.md) | [5,573](/filings/0001332349-25-000037.md) | [5,542](/filings/0001332349-24-000078.md) | [5,451](/filings/0001332349-24-000102.md) | [5,939](/filings/0001332349-24-000129.md) | [6,336](/filings/0001332349-26-000032.md) | [6,206](/filings/0001332349-25-000100.md) | [6,141](/filings/0001332349-25-000129.md) | [6,013](/filings/0001332349-25-000143.md) | [5,952](/filings/0001332349-26-000064.md) | [5,898](/filings/0001332349-26-000048.md) | [5,902](/filings/0001332349-26-000064.md) |
| Current liabilities | $m | [898](/filings/0001332349-23-000104.md) | [600](/filings/0001332349-25-000037.md) | [614](/filings/0001332349-24-000078.md) | [622](/filings/0001332349-24-000102.md) | [584](/filings/0001332349-24-000129.md) | [580](/filings/0001332349-26-000032.md) | [556](/filings/0001332349-25-000100.md) | [566](/filings/0001332349-25-000129.md) | [638](/filings/0001332349-25-000143.md) | [568](/filings/0001332349-26-000064.md) | [535](/filings/0001332349-26-000048.md) | [522](/filings/0001332349-26-000064.md) |
| Total liabilities | $m | [5,336](/filings/0001332349-23-000104.md) | [5,168](/filings/0001332349-25-000037.md) | [5,167](/filings/0001332349-24-000078.md) | [5,109](/filings/0001332349-24-000102.md) | [5,645](/filings/0001332349-24-000129.md) | [6,122](/filings/0001332349-26-000032.md) | [6,058](/filings/0001332349-25-000100.md) | [6,035](/filings/0001332349-25-000129.md) | [6,018](/filings/0001332349-25-000143.md) | [5,996](/filings/0001332349-26-000064.md) | [5,952](/filings/0001332349-26-000048.md) | [5,929](/filings/0001332349-26-000064.md) |
| Long-term debt | $m | [3,493](/filings/0001332349-23-000104.md) | [3,656](/filings/0001332349-25-000037.md) | [3,692](/filings/0001332349-24-000078.md) | [3,679](/filings/0001332349-24-000102.md) | [3,654](/filings/0001332349-24-000129.md) | [4,022](/filings/0001332349-26-000032.md) | [4,248](/filings/0001332349-25-000100.md) | [4,232](/filings/0001332349-25-000129.md) | [4,159](/filings/0001332349-25-000143.md) | [4,215](/filings/0001332349-26-000064.md) | [4,224](/filings/0001332349-26-000048.md) | [4,202](/filings/0001332349-26-000064.md) |
| Current portion of debt | $m | [305](/filings/0001332349-23-000104.md) | [41.5](/filings/0001332349-25-000037.md) | [65.7](/filings/0001332349-24-000078.md) | [60.9](/filings/0001332349-24-000102.md) | [51.5](/filings/0001332349-24-000129.md) | [40.8](/filings/0001332349-26-000032.md) | [64.1](/filings/0001332349-25-000100.md) | [59.2](/filings/0001332349-25-000129.md) | [104](/filings/0001332349-25-000143.md) | [77.5](/filings/0001332349-26-000064.md) | [82.6](/filings/0001332349-26-000048.md) | [70.9](/filings/0001332349-26-000064.md) |
| Shareholders' equity | $m | [492](/filings/0001332349-23-000104.md) | [404](/filings/0001332349-25-000037.md) | [374](/filings/0001332349-24-000078.md) | [340](/filings/0001332349-24-000102.md) | [293](/filings/0001332349-24-000129.md) | [212](/filings/0001332349-26-000032.md) | [147](/filings/0001332349-25-000100.md) | [105](/filings/0001332349-25-000129.md) | [(6.7)](/filings/0001332349-25-000143.md) | [(44.8)](/filings/0001332349-26-000064.md) | [(55.9)](/filings/0001332349-26-000048.md) | [(29.0)](/filings/0001332349-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [45.8 d](/filings/0001332349-24-000129.md) | [29.3 d](/filings/0001332349-26-000032.md) | [(1.1)](/filings/0001332349-25-000100.md) | [55.7 d](/filings/0001332349-25-000129.md) | [66.5 d](/filings/0001332349-25-000143.md) | [45.2 d](/filings/0001332349-26-000032.md) | [23.4](/filings/0001332349-26-000048.md) | [83.6 d](/filings/0001332349-26-000064.md) | [76.5 d](/filings/0001332349-25-000143.md) | [34.5 d](/filings/0001332349-26-000032.md) | [20.9](/filings/0001332349-26-000048.md) | [91.9 d](/filings/0001332349-26-000064.md) |
| Capital expenditure | $m | [64.9 d](/filings/0001332349-24-000129.md) | [58.5 d](/filings/0001332349-26-000032.md) | [44.4](/filings/0001332349-25-000100.md) | [51.6 d](/filings/0001332349-25-000129.md) | [55.0 d](/filings/0001332349-25-000143.md) | [50.3 d](/filings/0001332349-26-000032.md) | [41.8](/filings/0001332349-26-000048.md) | [54.5 d](/filings/0001332349-26-000064.md) | [41.6 d](/filings/0001332349-25-000143.md) | [63.7 d](/filings/0001332349-26-000032.md) | [46.5](/filings/0001332349-26-000048.md) | [48.4 d](/filings/0001332349-26-000064.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [187](/filings/0001332349-23-000104.md) | [225](/filings/0001332349-24-000078.md) | [225](/filings/0001332349-24-000102.md) | [225](/filings/0001332349-24-000129.md) | [226](/filings/0001332349-25-000100.md) | [227](/filings/0001332349-25-000129.md) | [228](/filings/0001332349-25-000143.md) | [231](/filings/0001332349-26-000048.md) | [235](/filings/0001332349-26-000064.md) | [237](/filings/0001332349-25-000143.md) | [238](/filings/0001332349-26-000048.md) | [244](/filings/0001332349-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 238,817,252 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001332349-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.